Dihydropyridine Calcium Channel Blocker Therapy and Risk of CKD Progression in Type 2 Diabetes Treated With Renin Angiotensin System Inhibitors and SGLT2 Inhibitors: A Real-World Retrospective Cohort Study

Rationale & Objective: Optimal antihypertensive therapy with renoprotective effects is essential to slow diabetic kidney disease progression. We evaluated the impact of dihydropyridine calcium channel blockers on kidney outcomes in patients with type 2 diabetes receiving guideline-directed renin...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Timna Agur, Tali Steinmetz, Shira Goldman, Boris Zingerman, Dana Bielopolski, Eviatar Nesher, Ittai Fattal, Eshcar Meisel, Benaya Rozen-Zvi
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Elsevier 2026-07-01
Schriftenreihe:	Kidney Medicine
Schlagworte:	all-cause mortality chronic kidney disease diabetes mellitus diabetic kidney disease dihydropyridine calcium channel blockers hypertension
Online-Zugang:	http://www.sciencedirect.com/science/article/pii/S2590059526001561
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!